Details of the Drug
General Information of Drug (ID: DM5O3HC)
| Drug Name |
Bouvardin
|
|||||
|---|---|---|---|---|---|---|
| Synonyms |
Bouvardin; MLS002703036; NSC259968; NSC 259968; NSC-259968; AC1L8NRS; Neuro_000123; SCHEMBL8739404; SMR001566844; From fraction F049 of Bouvardia ternifolia; Cyclic(D-alanyl-L-alanyl-N, cyclic(54.fwdarw.63)-ether, (S)-; 17,24-dihydroxy-10-(4-methoxybenzyl)-4,7,9,13,15,29-hexamethyl-22-oxa-3,6,9,12,15,29-hexaazatetracyclo[14.12.2.2~18,21~.1~23,27~]tritriaconta-18,20,23(31),24,26,32-hexaene-2,5,8,11,14,30-hexone
|
|||||
| Structure |
![]() |
|||||
| 3D MOL | 2D MOL | |||||
| #Ro5 Violations (Lipinski): 1 |
Molecular Weight | 772.8 | ||||
| Logarithm of the Partition Coefficient | Not Available | |||||
| Rotatable Bond Count | 3 | |||||
| Hydrogen Bond Donor Count | 5 | |||||
| Hydrogen Bond Acceptor Count | 10 | |||||
| Chemical Identifiers |
|
|||||
| Cross-matching ID | ||||||
| Drug ADMET Endpoint Profile (DAE)NEW | Click to Jump to the Detailed DAE Information of This Drug | |||||
Molecular Interaction Atlas of This Drug
![]() Drug Transporter (DTP) |
|
||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||


